AnalystsPatrick R. TrucchioPatrick R. Trucchio's Stock Forecasts
AnalystsPatrick R. Trucchio
Sectors:
Industries:
Analyst Ranking
Top 18%
#965 out of 5548 analysts
Average Return
+8.28%
Win Rate
36%45 out of 125
Risk vs Reward
Poor
Good
Patrick R. Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +885.34% | $3.41 | $33.60 | 2025-08-18 - 2026-08-17 | Buy |
Arrowhead Pharmaceuticals IncARWR | +222.20% | $25.68 | $82.74 | 2025-09-02 - 2026-09-01 | Buy |
Silence Therapeutics PLCSLN | +190.98% | $6.76 | $19.67 | 2026-06-17 - 2026-10-21 | Buy |
Silence Therapeutics PLCSLN | +185.07% | $6.90 | $19.67 | 2026-03-13 - 2026-10-21 | Buy |
Silence Therapeutics PLCSLN | +156.91% | $4.85 | $12.46 | 2025-09-16 - 2026-09-15 | Buy |
Patrick R. Trucchio Analyst Color
Get additional color on Patrick R. Trucchio's coverage of popular stocks
Patrick R. Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Silence Therapeutics PLCSLN | 4 | Hold | $20.00 | +1.73% | Downgrades | 2 days ago |
Alto Neuroscience IncANRO | 6 | Buy | $60.00 | +170.27% | Maintains | 4 days ago |
Beam Therapeutics IncBEAM | 5 | Buy | $80.00 | +225.73% | Reiterates | 8 days ago |
Arrowhead Pharmaceuticals IncARWR | 11 | Buy | $120.00 | +105.62% | Reiterates | 8 days ago |
Harmony Biosciences Holdings IncHRMY | 5 | Buy | $55.00 | +52.65% | Reiterates | 10 days ago |
Vir Biotechnology IncVIR | 4 | Buy | $22.00 | +110.93% | Maintains | 16 days ago |
Alnylam Pharmaceuticals IncALNY | 12 | Buy | $455.00 | +100.19% | Reiterates | a month ago |
Gossamer Bio IncGOSS | 6 | Buy | $90.00 | +851.37% | Maintains | a month ago |
Definium Therapeutics IncDFTX | 2 | Buy | $70.00 | +94.44% | Reiterates | a month ago |
Pharvaris NvPHVS | 5 | Buy | $60.00 | +95.57% | Reiterates | a month ago |
Nrx Pharmaceuticals IncNRXP | 7 | Buy | $45.00 | +1,775.00% | Reiterates | 2 months ago |
Bright Minds Biosciences IncDRUG | 6 | Buy | $145.00 | N/A | Reiterates | 2 months ago |
Oncolytics Biotech IncONCY | 3 | Buy | $5.00 | +900.00% | Maintains | 2 months ago |
Assembly Biosciences IncASMB | 5 | Buy | $50.00 | +146.55% | Reiterates | 2 months ago |
Faeth Therapeutics IncFTH | 2 | Buy | $60.00 | +198.51% | Reiterates | 2 months ago |
Voyager Therapeutics IncVYGR | 4 | Buy | $25.00 | +1,244.09% | Reiterates | 2 months ago |
Compass Pathways PLCCMPS | 4 | Buy | $65.00 | +458.90% | Maintains | 3 months ago |
Precision Biosciences IncDTIL | 3 | Buy | $60.00 | +784.96% | Reiterates | 3 months ago |
Ataibeckley IncATAI | 5 | Hold | $7.50 | +2.04% | Downgrades | 3 months ago |
Helus Pharma IncHELP | 3 | Buy | $70.00 | +566.67% | Maintains | 3 months ago |
Uniqure NvQURE | 9 | Buy | $80.00 | +246.17% | Maintains | 4 months ago |
Agomab Therapeutics NvAGMB | 1 | Buy | $35.00 | +277.97% | Initiates Coverage On | 4 months ago |
Invivyd IncIVVD | 4 | Buy | $10.00 | +1,539.34% | Reiterates | 4 months ago |
Gh Research PLCGHRS | 3 | Buy | $65.00 | +251.35% | Maintains | 5 months ago |
Altimmune IncALT | 4 | Buy | $20.00 | +821.66% | Maintains | 5 months ago |
Immunocore Holdings PLCIMCR | 4 | Buy | $100.00 | +211.33% | Reiterates | 6 months ago |
Aligos Therapeutics IncALGS | 3 | Buy | $50.00 | +937.34% | Reiterates | 7 months ago |
Sangamo Therapeutics IncSGMO | 2 | Buy | $10.00 | +8,595.65% | Reiterates | 8 months ago |
Marker Therapeutics IncMRKR | 1 | Buy | $10.00 | +834.58% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.